Language selection

Search

2017-07-25 - Unknown

901410615

Adverse reaction report number 901410615
Latest AER version number 1
Market authorization holder AER number CA201715712
Initial received date 2017-07-25
Latest received date 2017-10-09
Age N/A
Gender Unknown
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULESuspect Product used for unknown indication
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral15 Milligram1 every 1 Day(s) Product used for unknown indication

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug effect decreased
Euphoric mood
Product complaint
Date modified: